The Federal Investigation Agency (FIA) has sealed an illegal pharmaceutical facility in Rawat during a crackdown on counterfeit medicines. The FIA Anti-Corruption Circle in Islamabad conducted the operation at the facility located along G.T. Road. Officials discovered a large stock of suspected spurious and adulterated medicines during the raid.
The operation also uncovered pharmaceutical raw materials, packaging supplies, and machinery used for medicine production. The scale of the recovery has highlighted concerns surrounding unauthorised pharmaceutical manufacturing.
FIA Recovers Thousands of Medicines
According to the FIA, investigators recovered thousands of tablets, injections, syrup bottles, and cream tubes from the facility.
The seized stock included 14,961 tablets and 500 injections. Officials also recovered 20,900 syrup bottles belonging to different brands.
In addition, the raid uncovered 4,630 tubes of cream. Investigators also found packaged antibiotics and injectable formulations at the site.
Furthermore, officials recovered a significant quantity of pharmaceutical materials. The seized items included 1.5 million empty hard gelatin capsule shells and 66,258 empty bottles.
The FIA also seized 1,072 kilograms of raw materials from the facility. These materials included active pharmaceutical ingredients, nutraceutical materials, excipients, packaging supplies, and physician samples.
Production Machinery Found at Facility
The investigation also uncovered equipment that could support pharmaceutical manufacturing and packaging activities.
Officials found manufacturing and packaging machinery inside the facility. The presence of such equipment, along with medicines and raw materials, indicated the scale of the operation under investigation.
The FIA sealed the facility as authorities continue their crackdown on counterfeit and substandard medicines.
Such operations remain important because unauthorised pharmaceutical production can create serious risks for consumers. Medicines that contain incorrect ingredients or poor-quality materials may fail to provide the expected treatment.
Moreover, counterfeit products can enter legitimate supply chains if authorities do not detect illegal manufacturing operations. The Rawat raid therefore represents another effort to prevent unauthorised pharmaceutical production and protect consumers from potentially unsafe medicines.
Authorities are expected to examine the recovered medicines, raw materials, and equipment as part of the investigation. Further action may follow after officials establish the full scope of the alleged illegal operation.
